This inventor holds 1 USPTO granted patent. Top assignee: Bf Research Institute, Inc.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Masako Suzuki: Innovator in Diagnostic Probes for Tau Protein Accumulation
Introduction: Masako Suzuki is a prominent inventor based in Suita, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the imaging of diseases associated with tau protein accumulation. Her innovative work has the potential to enhance the diagnosis and treatment of neurodegenerative diseases.
Latest Patents: Masako Suzuki holds a patent for a quinoline derivative that serves as a diagnostic probe for diseases characterized by tau protein accumulation. The patent describes compounds, salts, or solvates that can be utilized for imaging diagnosis. Additionally, it includes methods for staining neurofibrillary tangles in brain samples and a pharmaceutical composition aimed at treating or preventing diseases linked to β-sheet structures. This patent highlights her commitment to advancing medical technology and improving patient outcomes. She has 1 patent to her name.
Career Highlights: Throughout her career, Masako Suzuki has been associated with Bf Research Institute, Inc., where she has collaborated with other talented researchers. Her work has been instrumental in developing diagnostic tools that can significantly impact the medical field.
Collaborations: Masako has worked alongside notable colleagues, including Yukitsuka Kudo and Takahiro Suemoto. Their combined expertise has contributed to the success of their research initiatives.
Conclusion: Masako Suzuki's innovative contributions to the field of diagnostic probes exemplify her dedication to advancing medical science. Her work not only enhances our understanding of tau protein-related diseases but also paves the way for improved diagnostic and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile